Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Businesses Solutions • Retail (& E-Commerce) • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Developer tools • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Robotics • Healthcare (& Wellness) • Investment Management • Life Science • Nanotechnology • Oncology • Pharmaceutical (& Medicine) |
Stages | Seed, Startup, Early Stage, Expansion, Series A, Series B |
Investing | Spain |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Alta Life Sciences is a multistage venture capital investment firm with expertise in equity investments and operates from its headquarters located on Passeig de Grcia in Barcelona, Spain. The firm plays an instrumental role in the life science and technology sectors with a broad investment strategy that encompasses a range of industries including Software, IT and TMT, BioTech, Business Solutions, Retail and E-Commerce, IoT and Wearables, AI and Big Data, HealthTech and Fitness, Developer Tools, Insurance and InsurTech, Medical Devices and Hospital Services, Robotics, Healthcare and Wellness, Investment Management, Life Science, Nanotechnology, Oncology, and Pharmaceutical and Medicine. Alta Life Sciences specializes in various funding stages, including Seed, Startup, Early Stage, Expansion, Series A, and Series B. With a flexible investment range between €100,000 and €5,000,000 and a sweet spot investment size of around €1,500,000, the fund seeks to support innovators across all stages of development, from seed financing through to commercial growth, particularly those based on breakthrough scientific discoveries that target unmet medical needs with significant societal impact. As a venture capital fund, Alta Life Sciences commits to identifying projects that offer investors the opportunity to access a dynamic and profitable market with high potential returns. Moreover, Alta Life Sciences serves as a bridge fund between Europe and the Americas, leveraging Barcelona's status as a vibrant and significant life sciences hub in Southern Europe. In partnership with AltamarCAM, the executives of Alta Life Sciences have launched Aliath Bioventures to further extend their reach and impact within the sector. They maintain a strong focus on investing in Biotechnology and Biopharma, Medical Devices, Diagnostics, Genomics, and Digital Health, pinpointing companies that show promising growth trajectories and the potential to deliver value to the healthcare ecosystem.